Shree Ganesh Remedies (NSE:SGRL) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SGRL Shree Ganesh Remedies Ltd NSE:SGRL
71 GF Score
Price ₹501.05
GF Value ₹589.26
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shree Ganesh Remedies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Shree Ganesh Remedies Valuation Rank Related Terms

NSE:SGRL
71GF Score
Shree Ganesh Remedies Ltd NSE:SGRL
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shree Ganesh Remedies (NSE:SGRL) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Remedies stock appears to be undervalued. The current stock price of ₹501.05 is trading 15% below its estimated GF Value™ of ₹589.26. GuruFocus considers Shree Ganesh Remedies to be Modestly Undervalued.

Key valuation signals for NSE:SGRL:

  • Valuation Rank:
  • GF Value™: ₹589.26 vs. price of ₹501.05 (15% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the NSE:SGRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shree Ganesh Remedies Business Description

Comparable Companies
Other Exchanges 540737:India
Address Plot No. 6002, 6003, 6011 & 6012, GIDC Industrial Estate, Bharuch, Ankleshwar, GJ, IND, 393002
Shree Ganesh Remedies Ltd manufactures drug intermediates, chemicals, and specialty fine chemicals for the pharmaceutical industry. The company offers pharmaceutical and specialty chemical products, including Trityl chloride, Furoyl chloride, and Dinitolmide. The company's business falls under the primary segment of Bulk Drug Intermediaries.
71GF Score

Get the complete analysis for NSE:SGRL

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹501.05
Price
₹589.26
GF Value